Loading company…
VIDEM develops molecular diagnostics for detecting infectious diseases at the point of care and in homes.
Founded in 2021, VIDEM develops molecular diagnostic technologies intended to provide rapid, accurate and affordable infectious disease detection at the point of care and in home settings. The company is based in Gothenburg, Sweden.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in